MACITENTAN

MACITENTAN was reported 69798 times

MACITENTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATHETER MANAGEMENT 336 0.3737
1 DEVICE WIRELESS COMMUNICATION ISSUE 86 0.3320
2 CATHETER SITE PRURITUS 278 0.3166
3 CATHETER SITE RASH 143 0.3164
4 CATHETER SITE IRRITATION 103 0.3093
5 CATHETER SITE SCAB 33 0.3084
6 PULMONARY ENDARTERECTOMY 43 0.2945
7 TRANSPLANT EVALUATION 149 0.2933
8 DEVICE MAINTENANCE ISSUE 162 0.2755
9 CATHETER SITE VESICLES 50 0.2564
10 CATHETER SITE WARMTH 41 0.2515
11 ATRIAL SEPTAL DEFECT REPAIR 43 0.2500
12 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 43 0.2471
13 CARDIAC OUTPUT INCREASED 42 0.2456
14 ENDARTERECTOMY 53 0.2366
15 CARDIAC FAILURE HIGH OUTPUT 57 0.2365
16 PULMONARY ARTERIAL HYPERTENSION 3310 0.2282
17 WALKING DISTANCE TEST ABNORMAL 84 0.2148
18 PULMONARY ARTERIAL PRESSURE INCREASED 336 0.2061
19 PULMONARY ARTERIAL PRESSURE ABNORMAL 59 0.2049
20 OXYGEN CONSUMPTION INCREASED 476 0.1990
21 CATHETER SITE ERYTHEMA 420 0.1961
22 CATHETER SITE DISCHARGE 215 0.1913
23 RIGHT VENTRICULAR FAILURE 1303 0.1857
24 PULMONARY VENO-OCCLUSIVE DISEASE 128 0.1829
25 INFUSION SITE INFECTION 398 0.1711
26 CATHETERISATION CARDIAC ABNORMAL 44 0.1630
27 VASCULAR DEVICE OCCLUSION 55 0.1622
28 PARACENTESIS 99 0.1610
29 INFUSION SITE DISCHARGE 277 0.1578
30 CATHETER SITE SWELLING 147 0.1571
31 RIGHT VENTRICULAR ENLARGEMENT 48 0.1500
32 VENTILATION PERFUSION MISMATCH 42 0.1495
33 CATHETER SITE PAIN 372 0.1432
34 INFUSION SITE WARMTH 173 0.1411
35 INFUSION SITE IRRITATION 177 0.1377
36 RIGHT VENTRICULAR DILATATION 76 0.1313
37 ABDOMINAL CAVITY DRAINAGE 55 0.1303
38 LUNG TRANSPLANT 453 0.1278
39 MINERAL SUPPLEMENTATION 57 0.1272
40 CREST SYNDROME 30 0.1261
41 INFUSION SITE PAIN 1611 0.1249
42 INFUSION SITE INDURATION 184 0.1241
43 DEVICE ALARM ISSUE 223 0.1227
44 DEVICE INFUSION ISSUE 304 0.1225
45 PERICARDIAL DRAINAGE 29 0.1213
46 PATIENT DISSATISFACTION WITH DEVICE 30 0.1190
47 INFUSION SITE HAEMORRHAGE 386 0.1172
48 INFUSION SITE VESICLES 59 0.1122
49 ASPIRATION PLEURAL CAVITY 85 0.1105
50 VASCULAR DEVICE INFECTION 500 0.1101
51 INFUSION SITE INFLAMMATION 77 0.1091
52 CATHETER SITE HAEMORRHAGE 273 0.1090
53 CATHETER SITE INFLAMMATION 61 0.1083
54 PULMONARY HYPERTENSIVE CRISIS 29 0.1070
55 INFUSION SITE ERYTHEMA 902 0.1069
56 INFUSION SITE DISCOLOURATION 94 0.1068
57 OXYGEN THERAPY 175 0.1064
58 INFUSION SITE CELLULITIS 54 0.1023
59 PULMONARY HYPERTENSION 2075 0.0995
60 DEPENDENCE ON OXYGEN THERAPY 49 0.0994
61 INFUSION SITE DISCOMFORT 103 0.0993
62 INFUSION SITE SWELLING 617 0.0980
63 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 31 0.0978
64 PULMONARY ARTERY DILATATION 33 0.0959
65 CATHETER REMOVAL 34 0.0952
66 CATHETER SITE EXTRAVASATION 38 0.0952
67 CATHETER PLACEMENT 176 0.0948
68 SYSTEMIC SCLERODERMA 68 0.0934
69 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 131 0.0932
70 CATHETERISATION CARDIAC 411 0.0926
71 INFUSION SITE ABSCESS 45 0.0893
72 RIGHT VENTRICULAR DYSFUNCTION 97 0.0879
73 TRANSFUSION 917 0.0874
74 HYPERVOLAEMIA 422 0.0853
75 BRAIN NATRIURETIC PEPTIDE INCREASED 262 0.0849
76 SCLERODERMA 308 0.0847
77 INFUSION SITE NODULE 81 0.0843
78 BIOPSY LUNG 30 0.0815
79 CATHETER SITE RELATED REACTION 60 0.0800
80 PAIN IN JAW 2238 0.0789
81 DYSPNOEA AT REST 226 0.0779
82 INFUSION SITE PRURITUS 245 0.0776
83 FLUID RETENTION 3872 0.0760
84 INFUSION SITE RASH 103 0.0750
85 PACKED RED BLOOD CELL TRANSFUSION 99 0.0748
86 CATHETER SITE INFECTION 279 0.0737
87 BIOPSY LIVER 30 0.0730
88 FLUID OVERLOAD 1032 0.0708
89 DIZZINESS EXERTIONAL 53 0.0697
90 DYSPNOEA EXERTIONAL 2597 0.0689
91 INFUSION SITE OEDEMA 51 0.0610
92 JUGULAR VEIN DISTENSION 34 0.0600
93 DEVICE RELATED SEPSIS 118 0.0586
94 CHRONIC RESPIRATORY FAILURE 69 0.0571
95 MEDICAL DEVICE CHANGE 30 0.0563
96 DERMATITIS CONTACT 636 0.0557
97 INFUSION SITE REACTION 164 0.0548
98 COR PULMONALE 52 0.0545
99 CONCOMITANT DISEASE AGGRAVATED 315 0.0510
100 SUTURE RELATED COMPLICATION 35 0.0495
101 CENTRAL VENOUS CATHETERISATION 145 0.0480
102 OXYGEN SATURATION DECREASED 2566 0.0456
103 LEFT VENTRICULAR FAILURE 156 0.0453
104 INFUSION SITE MASS 49 0.0451
105 CARDIOVERSION 62 0.0443
106 ANGIOPLASTY 64 0.0429
107 CARBON DIOXIDE INCREASED 58 0.0425
108 CARDIAC ABLATION 75 0.0419
109 SEASONAL ALLERGY 588 0.0415
110 DEVICE CONNECTION ISSUE 87 0.0412
111 HAEMOGLOBIN INCREASED 184 0.0403
112 THERAPY CHANGE 395 0.0401
113 NOCTURNAL DYSPNOEA 51 0.0400
114 LIVER TRANSPLANT 145 0.0398
115 ARTERIOVENOUS MALFORMATION 36 0.0396
116 ECHOCARDIOGRAM ABNORMAL 55 0.0393
117 OXYGEN SATURATION ABNORMAL 107 0.0377
118 HEART TRANSPLANT 34 0.0376
119 POLYPECTOMY 30 0.0375
120 PULMONARY PAIN 107 0.0366
121 CARDIAC OUTPUT DECREASED 32 0.0362
122 ORTHOPNOEA 114 0.0358
123 CONCOMITANT DISEASE PROGRESSION 68 0.0348
124 PURULENT DISCHARGE 148 0.0346
125 LUNG OPERATION 29 0.0346
126 BIOPSY 32 0.0345
127 DEVICE RELATED INFECTION 529 0.0343
128 NASAL CONGESTION 2000 0.0340
129 EXERCISE TOLERANCE DECREASED 194 0.0337
130 TRANSPLANT 80 0.0337
131 OEDEMA 1819 0.0335
132 REHABILITATION THERAPY 129 0.0333
133 HYPOXIA 1170 0.0332
134 TELANGIECTASIA 32 0.0332
135 EMERGENCY CARE 100 0.0329
136 DISEASE COMPLICATION 150 0.0327
137 DEVICE RELATED THROMBOSIS 31 0.0314
138 DEVICE POWER SOURCE ISSUE 91 0.0311
139 RESPIRATION ABNORMAL 213 0.0309
140 DIZZINESS POSTURAL 298 0.0307
141 ACUTE RESPIRATORY FAILURE 570 0.0296
142 DIALYSIS 412 0.0290
143 INJECTION SITE INFECTION 95 0.0289
144 MEDICAL PROCEDURE 48 0.0288
145 PERICARDIAL EFFUSION 659 0.0285
146 CARDIAC PACEMAKER INSERTION 168 0.0282
147 PULMONARY OEDEMA 1249 0.0279
148 ATRIAL FLUTTER 220 0.0275
149 HEART VALVE REPLACEMENT 40 0.0270
150 BLOOD PRESSURE SYSTOLIC DECREASED 123 0.0270
151 HOSPITALISATION 4147 0.0270
152 DEVICE OCCLUSION 375 0.0266
153 DRUG TOLERANCE DECREASED 74 0.0263
154 DRUG TITRATION ERROR 68 0.0263
155 PNEUMONIA INFLUENZAL 31 0.0260
156 INFUSION SITE BRUISING 56 0.0259
157 THERAPY NON-RESPONDER 1128 0.0251
158 UPPER RESPIRATORY TRACT INFLAMMATION 30 0.0250
159 THERAPEUTIC PROCEDURE 35 0.0250
160 CARDIAC FAILURE ACUTE 166 0.0249
161 BLOOD LOSS ANAEMIA 56 0.0247
162 LOCALISED OEDEMA 114 0.0246
163 IRON DEFICIENCY ANAEMIA 225 0.0244
164 INTENSIVE CARE 34 0.0239
165 ENDOTRACHEAL INTUBATION 67 0.0239
166 HOSPICE CARE 234 0.0237
167 WRONG DOSE 57 0.0236
168 VASODILATATION 59 0.0234
169 THROMBOSIS IN DEVICE 76 0.0232
170 TRACHEOSTOMY 33 0.0231
171 ASCITES 679 0.0231
172 BLOOD IRON DECREASED 273 0.0230
173 COMPLICATION ASSOCIATED WITH DEVICE 333 0.0229
174 EAR CONGESTION 62 0.0229
175 ATRIAL TACHYCARDIA 48 0.0228
176 PRODUCT ADMINISTRATION INTERRUPTED 179 0.0228
177 MIDDLE EAR EFFUSION 50 0.0226
178 SINUS CONGESTION 298 0.0220
179 HERNIA REPAIR 57 0.0219
180 HYPERCAPNIA 66 0.0219
181 OEDEMA PERIPHERAL 2636 0.0216
182 NASAL DRYNESS 135 0.0215
183 PULMONARY CONGESTION 282 0.0214
184 DYSPNOEA 12094 0.0213
185 CARDIAC OPERATION 183 0.0213
186 RALES 123 0.0212
187 INTERNAL HAEMORRHAGE 242 0.0212
188 PATIENT DISSATISFACTION WITH TREATMENT 40 0.0207
189 PORTAL HYPERTENSION 64 0.0207
190 PARANASAL SINUS HYPERSECRETION 79 0.0207
191 INTRA-ABDOMINAL FLUID COLLECTION 37 0.0206
192 PARANASAL SINUS DISCOMFORT 78 0.0206
193 PRODUCTIVE COUGH 978 0.0205
194 COLONOSCOPY 45 0.0204
195 HAEMOPTYSIS 558 0.0200
196 STAPHYLOCOCCUS TEST POSITIVE 42 0.0199
197 MECHANICAL VENTILATION 37 0.0195
198 RESPIRATORY TRACT CONGESTION 304 0.0191
199 EPISTAXIS 1416 0.0189
200 CARDIAC FAILURE 1515 0.0189
201 CARDIAC DISCOMFORT 38 0.0188
202 CHOKING SENSATION 102 0.0185
203 HYPOTENSION 3677 0.0183
204 PRESYNCOPE 445 0.0183
205 CHEMOTHERAPY 68 0.0180
206 PULSELESS ELECTRICAL ACTIVITY 74 0.0177
207 WALKING DISABILITY 37 0.0177
208 TERMINAL STATE 117 0.0175
209 MULTIPLE ALLERGIES 137 0.0175
210 PERIPHERAL SWELLING 2664 0.0173
211 HAEMATOLOGICAL INFECTION 41 0.0167
212 CARDIAC FAILURE CHRONIC 71 0.0166
213 INJECTION SITE DISCHARGE 88 0.0163
214 SYNCOPE 1614 0.0161
215 EYE CONTUSION 34 0.0161
216 SPUTUM DISCOLOURED 152 0.0160
217 FLUSHING 1629 0.0160
218 BLOOD POTASSIUM DECREASED 479 0.0159
219 OCCULT BLOOD POSITIVE 31 0.0158
220 RESPIRATORY FAILURE 1150 0.0158
221 PRODUCT LEAKAGE 87 0.0155
222 CHEST INJURY 32 0.0154
223 GOUT 277 0.0154
224 WEIGHT ABNORMAL 37 0.0154
225 CARDIOMEGALY 189 0.0153
226 PAINFUL RESPIRATION 37 0.0153
227 GASTROINTESTINAL TUBE INSERTION 38 0.0152
228 CARDIAC FAILURE CONGESTIVE 1221 0.0152
229 AMMONIA INCREASED 77 0.0151
230 PRODUCT DOSE OMISSION 969 0.0148
231 SINUS DISORDER 293 0.0148
232 DEVICE DISLOCATION 642 0.0148
233 STENT PLACEMENT 119 0.0147
234 IRON DEFICIENCY 66 0.0147
235 DECREASED ACTIVITY 157 0.0145
236 DEVICE FAILURE 221 0.0145
237 PULMONARY ALVEOLAR HAEMORRHAGE 81 0.0144
238 WEIGHT FLUCTUATION 151 0.0144
239 BLOOD PRESSURE DECREASED 957 0.0144
240 CARDIAC FLUTTER 93 0.0144
241 COUGH 4021 0.0143
242 INCORRECT DRUG ADMINISTRATION RATE 61 0.0143
243 PNEUMONIA 4605 0.0142
244 PLEURAL EFFUSION 865 0.0142
245 SINUS HEADACHE 84 0.0141
246 PNEUMONIA VIRAL 45 0.0141
247 BLOOD CULTURE POSITIVE 42 0.0140
248 VARICES OESOPHAGEAL 42 0.0139
249 RESPIRATORY TRACT INFECTION VIRAL 32 0.0137
250 LUNG OPACITY 36 0.0136
251 CHEST PAIN 2527 0.0136
252 FAECES SOFT 99 0.0136
253 RESPIRATORY SYNCYTIAL VIRUS INFECTION 118 0.0135
254 HYPOPNOEA 47 0.0135
255 HEPATIC CIRRHOSIS 254 0.0135
256 HEADACHE 8458 0.0135
257 UPPER-AIRWAY COUGH SYNDROME 111 0.0135
258 EAR DISCOMFORT 137 0.0133
259 GENERALISED OEDEMA 165 0.0133
260 CYANOSIS 209 0.0133
261 GASTRIC POLYPS 30 0.0133
262 LUNG DISORDER 646 0.0132
263 UPPER RESPIRATORY TRACT CONGESTION 38 0.0131
264 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 670 0.0128
265 BLOOD POTASSIUM ABNORMAL 34 0.0127
266 PULMONARY THROMBOSIS 139 0.0127
267 HAEMATOCRIT INCREASED 29 0.0127
268 PALPITATIONS 1477 0.0126
269 HEAD DISCOMFORT 223 0.0126
270 RHINOVIRUS INFECTION 49 0.0126
271 BREATH SOUNDS ABNORMAL 62 0.0126
272 CHEST DISCOMFORT 1275 0.0124
273 BILIRUBIN CONJUGATED INCREASED 29 0.0124
274 BLOOD COUNT ABNORMAL 188 0.0124
275 NON-CARDIAC CHEST PAIN 39 0.0123
276 SUPRAVENTRICULAR TACHYCARDIA 118 0.0123
277 HEART VALVE INCOMPETENCE 35 0.0122
278 PNEUMONIA BACTERIAL 112 0.0122
279 UNEVALUABLE EVENT 922 0.0122
280 SECRETION DISCHARGE 152 0.0121
281 BLOOD MAGNESIUM DECREASED 104 0.0120
282 THROAT IRRITATION 539 0.0120
283 URINE OUTPUT DECREASED 105 0.0120
284 DEVICE PHYSICAL PROPERTY ISSUE 92 0.0120
285 SWELLING 1113 0.0119
286 PULMONARY HAEMORRHAGE 93 0.0119
287 HEART RATE ABNORMAL 66 0.0118
288 GASTROENTERITIS VIRAL 213 0.0118
289 HAEMOGLOBIN DECREASED 1210 0.0118
290 IDIOPATHIC PULMONARY FIBROSIS 46 0.0116
291 TRICUSPID VALVE INCOMPETENCE 92 0.0116
292 INFUSION SITE EXTRAVASATION 72 0.0116
293 POLYURIA 94 0.0115
294 CARDIAC DYSFUNCTION 42 0.0113
295 CELLULITIS 568 0.0113
296 ABDOMINAL DISTENSION 1172 0.0112
297 HAEMATOCRIT DECREASED 222 0.0112
298 VIRAL UPPER RESPIRATORY TRACT INFECTION 53 0.0111
299 BLOOD BILIRUBIN INCREASED 300 0.0111
300 HEPATIC ENCEPHALOPATHY 103 0.0110
301 FOOD POISONING 59 0.0110
302 DIASTOLIC DYSFUNCTION 34 0.0110
303 ANAEMIA 2078 0.0109
304 OCULAR ICTERUS 47 0.0108
305 SLUGGISHNESS 110 0.0108
306 LOCALISED INFECTION 260 0.0107
307 BLOOD PRESSURE ABNORMAL 212 0.0107
308 RETCHING 225 0.0105
309 SARCOIDOSIS 50 0.0105
310 GASTRIC INFECTION 40 0.0104
311 CREPITATIONS 31 0.0104
312 BRONCHITIS 768 0.0104
313 DIARRHOEA 6680 0.0103
314 RHINORRHOEA 668 0.0103
315 SENSITIVITY TO WEATHER CHANGE 54 0.0103
316 CLOSTRIDIUM DIFFICILE INFECTION 222 0.0102
317 SKIN ABRASION 48 0.0101
318 OESOPHAGEAL DISORDER 39 0.0101
319 FAECES DISCOLOURED 219 0.0101
320 HEART RATE INCREASED 997 0.0101
321 ATRIAL FIBRILLATION 979 0.0100
322 DYSPEPSIA 982 0.0100
323 HAEMORRHOIDAL HAEMORRHAGE 48 0.0098
324 DEVICE LEAKAGE 426 0.0098
325 INFLUENZA 1092 0.0098
326 PNEUMOTHORAX 154 0.0097
327 HEAD INJURY 306 0.0097
328 NASOPHARYNGITIS 1771 0.0096
329 PRODUCT SUPPLY ISSUE 68 0.0095
330 RENAL DISORDER 443 0.0095
331 AORTIC STENOSIS 33 0.0095
332 CHOLECYSTECTOMY 108 0.0094
333 RENAL TRANSPLANT 34 0.0094
334 OROPHARYNGEAL PAIN 870 0.0094
335 ATYPICAL PNEUMONIA 28 0.0094
336 DEVICE KINK 34 0.0093
337 PULMONARY FIBROSIS 179 0.0093
338 INTERNATIONAL NORMALISED RATIO ABNORMAL 32 0.0093
339 BACTERAEMIA 110 0.0093
340 CARDIAC TAMPONADE 44 0.0092
341 HIP SURGERY 50 0.0092
342 DIZZINESS 4601 0.0092
343 DEVICE PLACEMENT ISSUE 33 0.0092
344 THERAPY CESSATION 473 0.0092
345 PAIN IN EXTREMITY 2713 0.0092
346 FACIAL BONES FRACTURE 33 0.0092
347 UPPER RESPIRATORY TRACT INFECTION 421 0.0091
348 SKIN LACERATION 99 0.0091
349 FLANK PAIN 85 0.0091
350 HYPOVOLAEMIA 53 0.0090
351 FACE INJURY 34 0.0089
352 RESPIRATORY DISTRESS 247 0.0089
353 TROPONIN INCREASED 68 0.0089
354 CATARACT OPERATION 53 0.0089
355 MOUTH HAEMORRHAGE 65 0.0089
356 DRY THROAT 90 0.0088
357 PERIPHERAL VENOUS DISEASE 36 0.0088
358 ABNORMAL LOSS OF WEIGHT 60 0.0088
359 HAEMODYNAMIC INSTABILITY 67 0.0088
360 VIRAL INFECTION 291 0.0087
361 CARDIOGENIC SHOCK 125 0.0087
362 DISEASE PROGRESSION 1029 0.0087
363 CONDITION AGGRAVATED 2639 0.0087
364 FUNCTIONAL GASTROINTESTINAL DISORDER 30 0.0087
365 DECREASED APPETITE 2013 0.0087
366 SKIN INFECTION 97 0.0086
367 GASTROINTESTINAL HAEMORRHAGE 721 0.0086
368 NO THERAPEUTIC RESPONSE 105 0.0086
369 DEATH 7416 0.0086
370 TOOTH EXTRACTION 107 0.0086
371 BLOOD SODIUM DECREASED 161 0.0085
372 PELVIC FRACTURE 66 0.0085
373 THERAPY PARTIAL RESPONDER 132 0.0085
374 BLOOD PRESSURE DIASTOLIC DECREASED 62 0.0084
375 DEAFNESS UNILATERAL 46 0.0083
376 CARDIAC DISORDER 780 0.0083
377 PERIORBITAL SWELLING 47 0.0083
378 RESPIRATORY TRACT INFECTION 216 0.0083
379 ULCER HAEMORRHAGE 56 0.0083
380 MALAISE 3624 0.0083
381 EYE OPERATION 38 0.0082
382 HAEMATEMESIS 209 0.0082
383 WEIGHT INCREASED 1838 0.0082
384 ABDOMINAL DISCOMFORT 1376 0.0082
385 GALLBLADDER OPERATION 33 0.0081
386 GASTROOESOPHAGEAL REFLUX DISEASE 652 0.0081
387 MUSCLE STRAIN 70 0.0081
388 HYSTERECTOMY 70 0.0081
389 OROPHARYNGEAL DISCOMFORT 73 0.0081
390 CARDIAC VALVE DISEASE 46 0.0080
391 TREATMENT NONCOMPLIANCE 439 0.0080
392 HYPOACUSIS 343 0.0080
393 MYALGIA 1354 0.0080
394 RESPIRATORY DISORDER 238 0.0079
395 HIP FRACTURE 255 0.0079
396 LIMB OPERATION 38 0.0079
397 SEPSIS 882 0.0079
398 BACTERIAL INFECTION 147 0.0079
399 HEART RATE IRREGULAR 178 0.0079
400 UNINTENTIONAL MEDICAL DEVICE REMOVAL 91 0.0079
401 APPENDICECTOMY 28 0.0078
402 COMPRESSION FRACTURE 42 0.0078
403 HIP ARTHROPLASTY 120 0.0078
404 GASTRIC HAEMORRHAGE 90 0.0078
405 NECK PAIN 434 0.0078
406 RENAL FUNCTION TEST ABNORMAL 36 0.0077
407 SUDDEN DEATH 82 0.0077
408 BLOOD UREA INCREASED 129 0.0077
409 SLEEP APNOEA SYNDROME 147 0.0077
410 CORONARY ARTERIAL STENT INSERTION 39 0.0077
411 INTERSTITIAL LUNG DISEASE 372 0.0077
412 THERAPY INTERRUPTED 547 0.0076
413 NAUSEA 6048 0.0076
414 ATELECTASIS 73 0.0075
415 POOR PERIPHERAL CIRCULATION 32 0.0075
416 LARGE INTESTINE POLYP 52 0.0075
417 ANAL INCONTINENCE 67 0.0074
418 STAPHYLOCOCCAL BACTERAEMIA 32 0.0074
419 LUNG INFECTION 114 0.0073
420 ARTHROPOD BITE 54 0.0073
421 TOE AMPUTATION 37 0.0073
422 CHOKING 142 0.0073
423 HYPERTHYROIDISM 105 0.0072
424 WEIGHT DECREASED 2024 0.0072
425 CREATININE RENAL CLEARANCE DECREASED 29 0.0072
426 TOOTH INFECTION 95 0.0072
427 BLOOD POTASSIUM INCREASED 117 0.0072
428 EAR PAIN 140 0.0072
429 FUNGAL SKIN INFECTION 29 0.0072
430 SINUSITIS 736 0.0072
431 CARDIOPULMONARY FAILURE 28 0.0072
432 HAEMOGLOBIN ABNORMAL 46 0.0071
433 FEELING ABNORMAL 1713 0.0071
434 FEELING COLD 199 0.0071
435 HAEMODIALYSIS 60 0.0071
436 LIMB INJURY 194 0.0071
437 MENTAL STATUS CHANGES 198 0.0071
438 ASPHYXIA 58 0.0071
439 FACIAL PAIN 63 0.0071
440 PROCEDURAL COMPLICATION 54 0.0070
441 ASPARTATE AMINOTRANSFERASE INCREASED 373 0.0070
442 APHONIA 98 0.0070
443 HEPATOMEGALY 69 0.0070
444 RHINITIS ALLERGIC 31 0.0070
445 EAR INFECTION 185 0.0069
446 LOSS OF CONSCIOUSNESS 881 0.0069
447 DEHYDRATION 917 0.0069
448 DRUG INTOLERANCE 664 0.0069
449 MELAENA 151 0.0069
450 RED BLOOD CELL COUNT DECREASED 196 0.0068
451 STAPHYLOCOCCAL INFECTION 226 0.0068
452 VOMITING 3220 0.0068
453 EMPHYSEMA 69 0.0068
454 SNEEZING 153 0.0068
455 UTERINE HAEMORRHAGE 29 0.0068
456 MALNUTRITION 76 0.0068
457 GASTROENTERITIS 99 0.0068
458 KIDNEY INFECTION 133 0.0068
459 ILLNESS 698 0.0068
460 FALL 2253 0.0068
461 BLOOD ALKALINE PHOSPHATASE INCREASED 168 0.0068
462 SMALL INTESTINAL OBSTRUCTION 83 0.0067
463 BEDRIDDEN 88 0.0067
464 TOOTHACHE 121 0.0067
465 SARS-COV-2 TEST POSITIVE 88 0.0067
466 CORONAVIRUS INFECTION 44 0.0066
467 DRUG DELIVERY SYSTEM MALFUNCTION 34 0.0066
468 ASTHENIA 2497 0.0066
469 ELECTROLYTE IMBALANCE 77 0.0066
470 FATIGUE 5154 0.0066
471 HYPERSOMNIA 189 0.0066
472 SKIN TIGHTNESS 31 0.0066
473 URINARY TRACT INFECTION 1120 0.0066
474 RIB FRACTURE 135 0.0066
475 LIMB DISCOMFORT 202 0.0065
476 CLOSTRIDIUM DIFFICILE COLITIS 69 0.0065
477 POOR QUALITY SLEEP 140 0.0065
478 STAPHYLOCOCCAL SEPSIS 32 0.0065
479 MULTIPLE ORGAN DYSFUNCTION SYNDROME 183 0.0065
480 OLIGURIA 40 0.0064
481 WHEEZING 382 0.0064
482 HYPOKALAEMIA 297 0.0064
483 SENSITIVE SKIN 47 0.0064
484 LIVER DISORDER 282 0.0064
485 SUBDURAL HAEMATOMA 91 0.0064
486 GASTRIC DISORDER 218 0.0063
487 INTERNATIONAL NORMALISED RATIO INCREASED 181 0.0063
488 RENAL IMPAIRMENT 532 0.0063
489 ABDOMINAL PAIN UPPER 1301 0.0063
490 MIGRAINE 603 0.0063
491 RESTLESS LEGS SYNDROME 114 0.0063
492 BLOOD LACTIC ACID INCREASED 33 0.0063
493 AUTOIMMUNE DISORDER 61 0.0063
494 ENDOCARDITIS 32 0.0062
495 ENTEROCOLITIS 36 0.0062
496 MUSCULOSKELETAL CHEST PAIN 96 0.0062
497 KNEE OPERATION 61 0.0062
498 ASTHENOPIA 34 0.0062
499 ADVERSE EVENT 566 0.0061
500 GASTROINTESTINAL DISORDER 547 0.0061
501 COVID-19 PNEUMONIA 72 0.0061
502 SPINAL OPERATION 75 0.0061
503 NEURALGIA 148 0.0061
504 NASAL DISCOMFORT 48 0.0060
505 BLOOD ALBUMIN DECREASED 48 0.0060
506 SEPTIC SHOCK 263 0.0060
507 HEART RATE DECREASED 212 0.0060
508 ANKLE FRACTURE 93 0.0060
509 HEAVY MENSTRUAL BLEEDING 54 0.0060
510 MUSCULOSKELETAL DISCOMFORT 103 0.0060
511 HAEMATOCHEZIA 330 0.0060
512 GASTROINTESTINAL MOTILITY DISORDER 32 0.0060
513 FAILURE TO THRIVE 31 0.0060
514 ATRIAL SEPTAL DEFECT 50 0.0060
515 LIVER FUNCTION TEST INCREASED 128 0.0060
516 SCIATICA 95 0.0060
517 FRUSTRATION TOLERANCE DECREASED 48 0.0059
518 POST PROCEDURAL COMPLICATION 114 0.0059
519 BACK PAIN 1376 0.0059
520 BLOOD URIC ACID INCREASED 34 0.0059
521 UPPER LIMB FRACTURE 117 0.0059
522 PRODUCT DOSE OMISSION ISSUE 1720 0.0058
523 TRISMUS 30 0.0058
524 VARICOSE VEIN 30 0.0058
525 GASTROINTESTINAL INFECTION 52 0.0058
526 CHILLS 680 0.0058
527 BLOOD PRESSURE FLUCTUATION 139 0.0058
528 POST PROCEDURAL INFECTION 47 0.0058
529 DEVICE INFORMATION OUTPUT ISSUE 45 0.0058
530 DIVERTICULITIS 160 0.0058
531 RESPIRATORY RATE INCREASED 51 0.0057
532 GENERAL PHYSICAL HEALTH DETERIORATION 664 0.0057
533 SWELLING OF EYELID 36 0.0057
534 CARDIAC ARREST 472 0.0057
535 SICKLE CELL ANAEMIA WITH CRISIS 90 0.0057
536 SPINAL COMPRESSION FRACTURE 47 0.0057
537 JOINT INJURY 121 0.0057
538 LIGAMENT SPRAIN 56 0.0057
539 RECTAL HAEMORRHAGE 243 0.0057
540 ARRHYTHMIA 265 0.0056
541 INFLUENZA LIKE ILLNESS 457 0.0055
542 JOINT SWELLING 670 0.0055
543 LUNG INFILTRATION 49 0.0055
544 GALLBLADDER DISORDER 99 0.0055
545 PLATELET COUNT DECREASED 591 0.0055
546 CHOLECYSTITIS 66 0.0055
547 TACHYCARDIA 492 0.0055
548 RENAL FAILURE 734 0.0055
549 LETHARGY 318 0.0055
550 POLYP 36 0.0055
551 UPPER GASTROINTESTINAL HAEMORRHAGE 92 0.0055
552 CANDIDA INFECTION 92 0.0054
553 SYSTEMIC LUPUS ERYTHEMATOSUS 193 0.0054
554 HAEMORRHOIDS 106 0.0054
555 KNEE ARTHROPLASTY 114 0.0054
556 BLOOD CREATININE INCREASED 353 0.0054
557 SKIN ULCER 139 0.0054
558 FLATULENCE 304 0.0054
559 MUSCULOSKELETAL PAIN 280 0.0053
560 HAEMORRHAGE 558 0.0053
561 FACE OEDEMA 90 0.0053
562 CYSTITIS 169 0.0053
563 LOWER LIMB FRACTURE 101 0.0053
564 WRIST FRACTURE 63 0.0053
565 BACK INJURY 57 0.0052
566 SURGERY 307 0.0052
567 INTESTINAL OBSTRUCTION 197 0.0052
568 BOWEL MOVEMENT IRREGULARITY 40 0.0052
569 DEVICE USE ERROR 181 0.0052
570 PNEUMONIA ASPIRATION 130 0.0052
571 PYREXIA 1797 0.0052
572 PROTHROMBIN TIME PROLONGED 31 0.0052
573 SWELLING FACE 337 0.0052
574 COLON CANCER 77 0.0052
575 DECUBITUS ULCER 42 0.0051
576 VITAMIN D DECREASED 44 0.0051
577 COVID-19 902 0.0051
578 SPINAL FRACTURE 103 0.0051
579 THROMBOSIS 413 0.0051
580 CHOLECYSTITIS ACUTE 29 0.0051
581 BLOOD DISORDER 41 0.0051
582 GAIT INABILITY 171 0.0051
583 INFECTION 740 0.0051
584 ACIDOSIS 39 0.0051
585 UROSEPSIS 47 0.0051
586 PHARYNGITIS STREPTOCOCCAL 55 0.0051
587 ALANINE AMINOTRANSFERASE INCREASED 312 0.0051
588 TACHYPNOEA 69 0.0051
589 DEVICE MALFUNCTION 356 0.0051
590 PLEURISY 30 0.0050
591 DYSPHONIA 294 0.0050
592 HYPERVENTILATION 29 0.0050
593 CHOLELITHIASIS 163 0.0050
594 FEELING OF BODY TEMPERATURE CHANGE 29 0.0049
595 MUSCLE TIGHTNESS 80 0.0049
596 DEAFNESS 129 0.0049
597 DEVICE ISSUE 442 0.0049
598 CONSTIPATION 1072 0.0049
599 TOOTH ABSCESS 50 0.0049
600 FEELING HOT 300 0.0049
601 POSTOPERATIVE WOUND INFECTION 33 0.0049
602 SPLENOMEGALY 57 0.0049
603 ASPIRATION 53 0.0048
604 GINGIVAL BLEEDING 66 0.0048
605 ORTHOSTATIC HYPOTENSION 84 0.0048
606 TASTE DISORDER 97 0.0048
607 PULMONARY MASS 71 0.0048
608 PALLOR 129 0.0047
609 BLOOD CALCIUM DECREASED 53 0.0047
610 HERNIA 91 0.0047
611 FREQUENT BOWEL MOVEMENTS 127 0.0047
612 FEEDING DISORDER 95 0.0047
613 PERIPHERAL COLDNESS 64 0.0047
614 ABDOMINAL PAIN 1084 0.0047
615 UNRESPONSIVE TO STIMULI 120 0.0046
616 ANURIA 40 0.0046
617 GASTRITIS 122 0.0046
618 PRODUCT DISTRIBUTION ISSUE 43 0.0046
619 HERPES ZOSTER 266 0.0046
620 LEFT VENTRICULAR DYSFUNCTION 31 0.0046
621 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 222 0.0046
622 END STAGE RENAL DISEASE 84 0.0046
623 LACRIMATION INCREASED 138 0.0046
624 ROAD TRAFFIC ACCIDENT 191 0.0046
625 PAIN 2798 0.0046
626 ERUCTATION 88 0.0045
627 HAND FRACTURE 32 0.0045
628 EYE INFECTION 51 0.0045
629 EYE HAEMORRHAGE 60 0.0045
630 COLD SWEAT 79 0.0045
631 HIATUS HERNIA 58 0.0045
632 THYROID DISORDER 69 0.0045
633 EXTRA DOSE ADMINISTERED 181 0.0045
634 GAMMA-GLUTAMYLTRANSFERASE INCREASED 99 0.0045
635 ARTHRALGIA 1856 0.0045
636 LUNG NEOPLASM MALIGNANT 182 0.0044
637 PRODUCT ADMINISTRATION ERROR 89 0.0044
638 ANGINA PECTORIS 126 0.0044
639 APPENDICITIS 41 0.0044
640 CONTUSION 422 0.0044
641 WOUND INFECTION 48 0.0044
642 MICTURITION URGENCY 50 0.0044
643 APPETITE DISORDER 29 0.0044
644 GASTROINTESTINAL PAIN 48 0.0044
645 POLLAKIURIA 181 0.0043
646 NERVE COMPRESSION 40 0.0043
647 ORAL CANDIDIASIS 57 0.0043
648 GROIN PAIN 38 0.0043
649 DRY MOUTH 349 0.0043
650 PHARYNGITIS 53 0.0043
651 INJECTION SITE IRRITATION 54 0.0042
652 UTERINE LEIOMYOMA 31 0.0042
653 GLOMERULAR FILTRATION RATE DECREASED 52 0.0042
654 WOUND 118 0.0042
655 POST PROCEDURAL HAEMORRHAGE 49 0.0042
656 FEELING JITTERY 80 0.0042
657 DRUG DOSE OMISSION 690 0.0042
658 FUNGAL INFECTION 139 0.0042
659 EYE SWELLING 155 0.0042
660 INJECTION SITE INDURATION 54 0.0042
661 CEREBRAL HAEMORRHAGE 149 0.0042
662 HOT FLUSH 313 0.0041
663 INSOMNIA 1105 0.0041
664 MUSCLE SPASMS 761 0.0041
665 LACERATION 39 0.0041
666 SUBARACHNOID HAEMORRHAGE 42 0.0041
667 INSURANCE ISSUE 63 0.0041
668 ARTHRITIS 324 0.0041
669 BONE PAIN 241 0.0041
670 OCULAR DISCOMFORT 46 0.0041
671 DEVICE BREAKAGE 166 0.0041
672 ACUTE KIDNEY INJURY 623 0.0041
673 CARDIO-RESPIRATORY ARREST 170 0.0041
674 HEPATIC FUNCTION ABNORMAL 151 0.0040
675 CARDIAC MURMUR 35 0.0040
676 FULL BLOOD COUNT DECREASED 81 0.0040
677 BACK DISORDER 65 0.0040
678 MEMORY IMPAIRMENT 549 0.0040
679 SCRATCH 42 0.0040
680 RASH PRURITIC 215 0.0040
681 ULCER 63 0.0040
682 WHITE BLOOD CELL COUNT INCREASED 151 0.0039
683 BODY TEMPERATURE INCREASED 80 0.0039
684 IMPAIRED GASTRIC EMPTYING 53 0.0039
685 HEPATIC FAILURE 117 0.0039
686 TINNITUS 178 0.0039
687 SCAB 44 0.0039
688 DYSURIA 142 0.0039
689 FOOT FRACTURE 73 0.0038
690 LABORATORY TEST ABNORMAL 113 0.0038
691 BRAIN FOG 60 0.0038
692 PHOTOPHOBIA 72 0.0038
693 INCREASED TENDENCY TO BRUISE 35 0.0038
694 DEVICE USE ISSUE 66 0.0038
695 BLOOD TEST ABNORMAL 53 0.0038
696 NERVOUSNESS 197 0.0038
697 ESCHERICHIA INFECTION 31 0.0038
698 EATING DISORDER 80 0.0038
699 OSTEOMYELITIS 68 0.0038
700 ADVERSE DRUG REACTION 336 0.0037
701 MITRAL VALVE INCOMPETENCE 42 0.0037
702 CIRCULATORY COLLAPSE 63 0.0037
703 SHOCK 85 0.0037
704 VENTRICULAR TACHYCARDIA 61 0.0037
705 TEMPERATURE INTOLERANCE 38 0.0037
706 FACIAL PARALYSIS 31 0.0036
707 CHROMATURIA 82 0.0036
708 BLADDER DISORDER 36 0.0036
709 RENAL PAIN 38 0.0036
710 SKIN DISCOLOURATION 164 0.0036
711 GAIT DISTURBANCE 683 0.0036
712 HYPOPHAGIA 91 0.0036
713 HAEMATOMA 92 0.0035
714 ILEUS 44 0.0035
715 INFLAMMATION 181 0.0035
716 BLOOD URINE PRESENT 66 0.0035
717 THROAT TIGHTNESS 93 0.0034
718 PULMONARY EMBOLISM 325 0.0034
719 PSEUDOMONAS INFECTION 29 0.0034
720 ROTATOR CUFF SYNDROME 43 0.0033
721 ADVERSE REACTION 44 0.0033
722 FULL BLOOD COUNT ABNORMAL 35 0.0033
723 ORAL PAIN 74 0.0033
724 LEUKAEMIA 31 0.0033
725 VISUAL IMPAIRMENT 404 0.0033
726 SOMNOLENCE 656 0.0033
727 VERTIGO 198 0.0032
728 MUSCULAR WEAKNESS 369 0.0032
729 ERYTHEMA 666 0.0032
730 ABNORMAL WEIGHT GAIN 40 0.0032
731 PANIC ATTACK 118 0.0032
732 ANXIETY 917 0.0032
733 OCULAR HYPERAEMIA 151 0.0032
734 BLOOD GLUCOSE DECREASED 152 0.0032
735 LIVER FUNCTION TEST ABNORMAL 92 0.0032
736 MENORRHAGIA 62 0.0032
737 GASTRIC ULCER 60 0.0032
738 HYPONATRAEMIA 177 0.0031
739 LYMPHADENOPATHY 111 0.0031
740 DEVICE ADHESION ISSUE 48 0.0031
741 VISION BLURRED 429 0.0031
742 HYPOAESTHESIA 467 0.0031
743 OESOPHAGITIS 34 0.0031
744 DIARRHOEA HAEMORRHAGIC 29 0.0031
745 PNEUMONITIS 84 0.0031
746 TRANSIENT ISCHAEMIC ATTACK 104 0.0031
747 THIRST 55 0.0031
748 ABSCESS 49 0.0031
749 LOWER RESPIRATORY TRACT INFECTION 139 0.0031
750 DEPRESSED MOOD 161 0.0030
751 COLITIS 115 0.0030
752 BRONCHOSPASM 43 0.0030
753 RESPIRATORY ARREST 83 0.0030
754 ABDOMINAL PAIN LOWER 76 0.0030
755 TREMOR 498 0.0030
756 MUSCLE ATROPHY 38 0.0030
757 ACUTE RESPIRATORY DISTRESS SYNDROME 53 0.0030
758 HYPERBILIRUBINAEMIA 31 0.0030
759 LEUKOCYTOSIS 54 0.0030
760 NEOPLASM MALIGNANT 199 0.0030
761 QUALITY OF LIFE DECREASED 40 0.0030
762 INTENTIONAL DOSE OMISSION 85 0.0030
763 ACCIDENTAL OVERDOSE 108 0.0029
764 EYELID OEDEMA 34 0.0029
765 CATARACT 173 0.0029
766 TOOTH FRACTURE 32 0.0029
767 SINUS TACHYCARDIA 41 0.0029
768 DYSPHAGIA 274 0.0029
769 HYPOMAGNESAEMIA 40 0.0029
770 PRODUCT USE ISSUE 538 0.0029
771 HYPOTHYROIDISM 91 0.0028
772 MACULAR DEGENERATION 34 0.0028
773 FEMUR FRACTURE 88 0.0028
774 URINARY INCONTINENCE 84 0.0028
775 TOOTH DISORDER 63 0.0028
776 COAGULOPATHY 47 0.0028
777 DYSSTASIA 82 0.0028
778 AGEUSIA 70 0.0028
779 FRACTURE 53 0.0028
780 BALANCE DISORDER 242 0.0028
781 SKIN IRRITATION 128 0.0028
782 MASS 39 0.0028
783 DERMATITIS ALLERGIC 35 0.0028
784 BLOOD PRESSURE SYSTOLIC INCREASED 54 0.0028
785 NEUROPATHY PERIPHERAL 263 0.0028
786 NIGHT SWEATS 89 0.0028
787 HYPOKINESIA 40 0.0028
788 DISCOMFORT 168 0.0028
789 CONFUSIONAL STATE 445 0.0028
790 BURNING SENSATION 193 0.0027
791 APATHY 40 0.0027
792 SLEEP DISORDER 193 0.0027
793 NEPHROLITHIASIS 125 0.0027
794 HYPERTENSION 576 0.0027
795 HYPERKALAEMIA 95 0.0027
796 JOINT STIFFNESS 71 0.0027
797 HYPERSENSITIVITY 491 0.0026
798 PRURITUS 1006 0.0026
799 MOBILITY DECREASED 186 0.0026
800 HYPOAESTHESIA ORAL 39 0.0026
801 PANCYTOPENIA 144 0.0026
802 DEMENTIA 72 0.0026
803 DISORIENTATION 102 0.0026
804 APPLICATION SITE PRURITUS 58 0.0026
805 EYE DISORDER 84 0.0026
806 IRRITABLE BOWEL SYNDROME 54 0.0025
807 IMMUNE SYSTEM DISORDER 33 0.0025
808 C-REACTIVE PROTEIN INCREASED 91 0.0025
809 CEREBROVASCULAR ACCIDENT 423 0.0025
810 SKIN HAEMORRHAGE 37 0.0025
811 ACCIDENT 29 0.0024
812 INTERVERTEBRAL DISC PROTRUSION 53 0.0024
813 BRADYCARDIA 128 0.0024
814 APPLICATION SITE IRRITATION 30 0.0024
815 PARAESTHESIA 378 0.0024
816 HYPERHIDROSIS 309 0.0024
817 AMNESIA 156 0.0024
818 BURSITIS 29 0.0024
819 ADRENAL INSUFFICIENCY 29 0.0024
820 NODULE 31 0.0024
821 RASH 1029 0.0024
822 ENCEPHALOPATHY 57 0.0023
823 INJECTION SITE DISCOLOURATION 29 0.0023
824 RASH MACULAR 81 0.0023
825 MOOD ALTERED 63 0.0023
826 HEMIPARESIS 39 0.0023
827 PLATELET COUNT INCREASED 30 0.0023
828 ASTHMA 259 0.0023
829 CARPAL TUNNEL SYNDROME 32 0.0023
830 EYE PAIN 128 0.0023
831 PERICARDITIS 38 0.0023
832 BLISTER 127 0.0023
833 SEIZURE 261 0.0023
834 THINKING ABNORMAL 42 0.0023
835 ORAL DISCOMFORT 31 0.0022
836 PRODUCT DOSE OMISSION IN ERROR 63 0.0022
837 VAGINAL HAEMORRHAGE 96 0.0022
838 DRUG ERUPTION 39 0.0022
839 RASH ERYTHEMATOUS 105 0.0022
840 CORONARY ARTERY OCCLUSION 30 0.0022
841 MYOCARDIAL INFARCTION 379 0.0022
842 HEPATIC ENZYME INCREASED 148 0.0022
843 BLOOD GLUCOSE ABNORMAL 40 0.0022
844 LYMPHOMA 33 0.0021
845 URINARY RETENTION 71 0.0021
846 PRURITUS GENERALISED 46 0.0021
847 JAUNDICE 57 0.0021
848 THROMBOCYTOPENIA 235 0.0021
849 GLAUCOMA 40 0.0021
850 HAEMATURIA 71 0.0021
851 DIABETES MELLITUS 158 0.0021
852 EXPOSURE DURING PREGNANCY 128 0.0021
853 RESTLESSNESS 75 0.0020
854 CORONARY ARTERY DISEASE 62 0.0020
855 SKIN DISORDER 68 0.0020
856 PANCREATITIS 107 0.0020
857 DISABILITY 40 0.0020
858 HAEMORRHAGE INTRACRANIAL 30 0.0020
859 TRANSAMINASES INCREASED 44 0.0020
860 BLOOD PRESSURE INCREASED 302 0.0020
861 UNDERDOSE 144 0.0020
862 DEPRESSION 448 0.0020
863 EYE PRURITUS 66 0.0020
864 DYSGEUSIA 144 0.0019
865 SPEECH DISORDER 101 0.0019
866 ARTHROPATHY 107 0.0019
867 OSTEOPOROSIS 79 0.0019
868 INJECTION SITE ERYTHEMA 237 0.0019
869 WHITE BLOOD CELL COUNT DECREASED 207 0.0019
870 CRYING 69 0.0019
871 INJECTION SITE WARMTH 39 0.0019
872 LOCAL SWELLING 33 0.0019
873 APHASIA 57 0.0019
874 INCREASED APPETITE 36 0.0019
875 MIDDLE INSOMNIA 35 0.0019
876 HYPOGLYCAEMIA 90 0.0019
877 RASH GENERALISED 48 0.0019
878 PRODUCT PREPARATION ERROR 38 0.0018
879 ORAL HERPES 36 0.0018
880 PRODUCT USE COMPLAINT 29 0.0018
881 PROCEDURAL PAIN 51 0.0018
882 HEPATIC CANCER 44 0.0018
883 OBESITY 29 0.0018
884 SCAR 31 0.0018
885 FIBROMYALGIA 44 0.0018
886 PANCREATIC CARCINOMA 52 0.0018
887 INJECTION SITE PRURITUS 120 0.0018
888 CHRONIC KIDNEY DISEASE 136 0.0018
889 METASTASES TO LIVER 31 0.0018
890 DERMATITIS 36 0.0017
891 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 122 0.0017
892 BLINDNESS 69 0.0017
893 DEEP VEIN THROMBOSIS 110 0.0017
894 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 303 0.0017
895 MENTAL DISORDER 73 0.0017
896 LIVER INJURY 41 0.0017
897 INJECTION SITE HAEMORRHAGE 132 0.0017
898 MENTAL IMPAIRMENT 40 0.0016
899 AGITATION 119 0.0016
900 OFF LABEL USE 1401 0.0016
901 AMENORRHOEA 28 0.0016
902 ACUTE MYOCARDIAL INFARCTION 47 0.0016
903 MUSCULOSKELETAL DISORDER 30 0.0016
904 THERAPEUTIC RESPONSE DECREASED 95 0.0016
905 INJECTION SITE RASH 48 0.0016
906 RASH PAPULAR 35 0.0016
907 CEREBRAL INFARCTION 38 0.0016
908 DIPLOPIA 40 0.0015
909 LIP SWELLING 51 0.0015
910 APPLICATION SITE ERYTHEMA 40 0.0015
911 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
912 URTICARIA 254 0.0015
913 INCORRECT DOSE ADMINISTERED 343 0.0015
914 INJECTION SITE SWELLING 115 0.0015
915 MUSCULOSKELETAL STIFFNESS 131 0.0015
916 EXPOSURE VIA SKIN CONTACT 38 0.0015
917 IMPAIRED HEALING 48 0.0015
918 DEVICE DIFFICULT TO USE 95 0.0014
919 PANCREATITIS ACUTE 32 0.0014
920 DYSARTHRIA 53 0.0014
921 COMA 67 0.0014
922 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
923 GASTRIC CANCER 35 0.0014
924 INJECTION SITE PAIN 423 0.0014
925 DRY SKIN 183 0.0014
926 ILL-DEFINED DISORDER 83 0.0014
927 EYE IRRITATION 78 0.0014
928 GLOSSODYNIA 30 0.0013
929 INCORRECT DOSE ADMINISTERED BY DEVICE 35 0.0013
930 NEEDLE ISSUE 38 0.0013
931 DRY EYE 65 0.0013
932 MUSCLE TWITCHING 30 0.0013
933 OSTEOARTHRITIS 55 0.0013
934 IRRITABILITY 78 0.0013
935 MOVEMENT DISORDER 41 0.0013
936 PRODUCT AVAILABILITY ISSUE 29 0.0013
937 DEPRESSED LEVEL OF CONSCIOUSNESS 50 0.0013
938 DELIRIUM 43 0.0012
939 BREAST CANCER 115 0.0012
940 DYSKINESIA 50 0.0012
941 SKIN LESION 33 0.0012
942 INTENTIONAL PRODUCT USE ISSUE 105 0.0012
943 PAIN OF SKIN 32 0.0012
944 DRUG INTERACTION 188 0.0012
945 DRUG ADMINISTRATION ERROR 36 0.0012
946 DISTURBANCE IN ATTENTION 63 0.0012
947 HYPERGLYCAEMIA 42 0.0012
948 EMOTIONAL DISORDER 35 0.0011
949 HEPATITIS 29 0.0011
950 FEAR 30 0.0011
951 DEVICE DELIVERY SYSTEM ISSUE 30 0.0011
952 RHEUMATOID ARTHRITIS 124 0.0011
953 COGNITIVE DISORDER 50 0.0011
954 METABOLIC ACIDOSIS 34 0.0011
955 PREMATURE BABY 32 0.0011
956 ECZEMA 55 0.0010
957 LACTIC ACIDOSIS 34 0.0010
958 THERAPEUTIC RESPONSE UNEXPECTED 47 0.0010
959 ALOPECIA 204 0.0010
960 BLOOD GLUCOSE INCREASED 191 0.0010
961 HALLUCINATION 72 0.0010
962 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 44 0.0009
963 INJURY 66 0.0009
964 STOMATITIS 55 0.0009
965 SKIN EXFOLIATION 76 0.0009
966 TYPE 2 DIABETES MELLITUS 30 0.0009
967 ANGER 29 0.0009
968 PRODUCT USE IN UNAPPROVED INDICATION 208 0.0008
969 BLOOD CHOLESTEROL INCREASED 39 0.0008
970 PLASMA CELL MYELOMA 32 0.0008
971 MEDICATION ERROR 44 0.0008
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 155 0.0008
973 DRUG INEFFECTIVE 981 0.0007
974 OVERDOSE 157 0.0007
975 ACCIDENTAL EXPOSURE TO PRODUCT 74 0.0007
976 LEUKOPENIA 35 0.0007
977 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
979 ANGIOEDEMA 28 0.0006
980 SKIN BURNING SENSATION 45 0.0006
981 BLADDER CANCER 36 0.0006
982 MATERNAL EXPOSURE DURING PREGNANCY 53 0.0006
983 INJECTION SITE REACTION 40 0.0006
984 INJECTION SITE BRUISING 44 0.0006
985 ACNE 40 0.0005
986 INTENTIONAL PRODUCT MISUSE 45 0.0005
987 SUICIDAL IDEATION 46 0.0005
988 TREATMENT FAILURE 35 0.0004
989 NO ADVERSE EVENT 62 0.0003
990 PSORIASIS 43 0.0003
991 NEUTROPENIA 42 0.0003
992 EMOTIONAL DISTRESS 37 0.0003
993 TOXICITY TO VARIOUS AGENTS 50 0.0003